Middle East & Africa Active Pharmaceutical Ingredients Market Outlook, 2027

The Middle East & Africa active pharmaceutical ingredient market is projected to boom in the upcoming years while exhibiting an impressive CAGR. In last five years, from 2017 to 2021, market has experienced quite a growth that was counted in millions of sales. The project growth in the forecast period is 2022-2027, on account of a surge in demand for effective with efficient pharmaceutical products. The increasing instances of chronic diseases with complex treatment strategies are demanding the presence of active pharmaceutical ingredients. The Middle East & Africa active pharmaceutical ingredient market is segmented in the prominent countries like Saudi Arabia, UAE, South Africa, have dedicated research labs for advanced products development and consistent product modifications. The Middle East & Africa is expected to witness a low growth over the forecast years due to the lack of awareness about APIs in this region. According to therapeutic application, the active pharmaceutical ingredients (API) market is segmented into cardiology, CNS & neurology, oncology, orthopaedic, endocrinology, pulmonology, gastroenterology, nephrology, ophthalmology, gynaecology and other therapeutic application.

By 2027, cardiology segment is expected to dominate with more than 20% CAGR in the Middle East & Africa Active Pharmaceutical Ingredients (API) market because of rising number of cardiac diseases such as heart attack, heart failure, embolism and others. The captive API manufacturer segment is expected to dominate the active pharmaceutical ingredients (API) market due to huge investment by major market players to generate high end, manufacturing facilities and easy availability of raw materials. , the captive segment is the largest share in 2018 owing to fast capitalization of major key companies in the development of high-end manufacturing plants and the availability of raw materials. The Merchant API segment is supposed to be the fastest growing segment owing to factors such as, increasing demand for biopharmaceuticals and high cost of in-house manufacturing of these molecules. UAE is estimated to be the fastest-growing region over the forecast period. The Availability of cheap labour and lenient regulatory framework are attracting foreign nations to set up manufacturing facilities in MEA. UAE pharmaceutical market to be valued at 0.68 Billion by 2025 as it boost local manufacturings.

According to the report titled "Middle East & Africa Active Pharmaceutical Ingredients Market Outlook, 2027", published by Bonafide Research, the Middle East & Africa Active Pharmaceutical Ingredients market size was valued at USD 4.91 Billion in 2020 and is expected to expand at a CAGR of more than 6% from 2022 to 2027.

The increasing healthcare expenditure is expected to drive the UAE heart attack treatment drugs market growth during the forecast period.

Covid-19 impact
The COVID-19 has had far-reaching consequences on the physical and mental health of individuals as well as the health of economies across the globe. While young people may be less susceptible to severe forms of the illness, suffering milder symptoms, lower morbidity, High mortality and better prognosis compared to adults they have experienced an upsurge in stress precipitating loneliness, anxiety and depression, saving loss. An emotional symptom in adolescence can become associated with many serious mental health outcomes including suicide, long-term physical health consequences, and healthcare burden, stress. The effect of coronavirus on young people's mental health could be more damaging in the longer run than the infection itself. Measuring onset signs of mental health challenges such as worries and negative emotions in young people is thus an urgent priority for researchers as well as policy-makers, including identifying those most vulnerable to mental health difficulties. This information is crucial for both high and low income countries, with lower resources dedicated to mental health may benefit more from early forecasts of these needs.

Major Companies present in the market:
Aurobindo Pharma Limited, Cipla Limited, Dr. Reddy’s Laboratories Limited, Lupin Limited, Sun Pharmaceutical Industries Limited, Pfizer Inc., Novartis International AG, Biocon Limited, Sanofi S.A., Teva Pharmaceutical Industries Limited, AbbVie Inc., GlaxoSmithKline plc., Merck & Co., Inc., Viatris Inc., Bristol-Myers Squibb Company

Considered in this report
• Geography: Middle East & Africa
• Historic Year: 2016
• Base year: 2021
• Estimated year: 2022
• Forecast year: 2027

Aspects covered in this report
• Middle East & Africal Active Pharmaceutical Ingredients Market with its value and forecast along with its segments
• Region & country wise Active Pharmaceutical Ingredients market analysis
• Application wise Active Pharmaceutical Ingredients distribution
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Regions covered in the report
• UAE
• Saudi Arabia
• South Africa

Based on synthesis of Active Pharmaceutical Ingredients in the report:
• Synthetic APIs
• Biotech APIs

Based on drug type of Active Pharmaceutical Ingredients in the report:
• Branded APIs
• Generic APIs

Based on type of manufacture of Active Pharmaceutical Ingredients in the report:
• Captive APIs
• Merchant APIs

By Therapeutic Application Type in the report:
• Communicable Diseases
• Oncology
• Diabetes
• Cardiovascular Disease
• Pain management
• Respiratory Diseases
• Other Therapeutic Applications

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and listing out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, annual report of companies, analysing the government generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducted trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers in regional aspects, tier aspects, age group, and gender. Once we have primary data with us we have started verifying the details obtained from secondary sources.

Intended audience
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to pharmaceutical industry, government bodies and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Ask an Expert

Manmayi Raval

Research Consultant

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now